Prophylactic HIV Drug Market - Global Outlook and Forecast 2023-2028

Report ID: 1377376 | Published Date: Jan 2025 | No. of Page: 77 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Prophylactic HIV Drug Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Prophylactic HIV Drug Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Prophylactic HIV Drug Overall Market Size
    2.1 Global Prophylactic HIV Drug Market Size: 2021 VS 2028
    2.2 Global Prophylactic HIV Drug Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Prophylactic HIV Drug Sales: 2017-2028
3 Company Landscape
    3.1 Top Prophylactic HIV Drug Players in Global Market
    3.2 Top Global Prophylactic HIV Drug Companies Ranked by Revenue
    3.3 Global Prophylactic HIV Drug Revenue by Companies
    3.4 Global Prophylactic HIV Drug Sales by Companies
    3.5 Global Prophylactic HIV Drug Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Prophylactic HIV Drug Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Prophylactic HIV Drug Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Prophylactic HIV Drug Players in Global Market
        3.8.1 List of Global Tier 1 Prophylactic HIV Drug Companies
        3.8.2 List of Global Tier 2 and Tier 3 Prophylactic HIV Drug Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Prophylactic HIV Drug Market Size Markets, 2021 & 2028
        4.1.2 Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI)
        4.1.3 Integrase Inhibitor
    4.2 By Type - Global Prophylactic HIV Drug Revenue & Forecasts
        4.2.1 By Type - Global Prophylactic HIV Drug Revenue, 2017-2022
        4.2.2 By Type - Global Prophylactic HIV Drug Revenue, 2023-2028
        4.2.3 By Type - Global Prophylactic HIV Drug Revenue Market Share, 2017-2028
    4.3 By Type - Global Prophylactic HIV Drug Sales & Forecasts
        4.3.1 By Type - Global Prophylactic HIV Drug Sales, 2017-2022
        4.3.2 By Type - Global Prophylactic HIV Drug Sales, 2023-2028
        4.3.3 By Type - Global Prophylactic HIV Drug Sales Market Share, 2017-2028
    4.4 By Type - Global Prophylactic HIV Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Prophylactic HIV Drug Market Size, 2021 & 2028
        5.1.2 Hospital Pharmacy
        5.1.3 Retail Pharmacy
        5.1.4 Online Pharmacy
    5.2 By Application - Global Prophylactic HIV Drug Revenue & Forecasts
        5.2.1 By Application - Global Prophylactic HIV Drug Revenue, 2017-2022
        5.2.2 By Application - Global Prophylactic HIV Drug Revenue, 2023-2028
        5.2.3 By Application - Global Prophylactic HIV Drug Revenue Market Share, 2017-2028
    5.3 By Application - Global Prophylactic HIV Drug Sales & Forecasts
        5.3.1 By Application - Global Prophylactic HIV Drug Sales, 2017-2022
        5.3.2 By Application - Global Prophylactic HIV Drug Sales, 2023-2028
        5.3.3 By Application - Global Prophylactic HIV Drug Sales Market Share, 2017-2028
    5.4 By Application - Global Prophylactic HIV Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Prophylactic HIV Drug Market Size, 2021 & 2028
    6.2 By Region - Global Prophylactic HIV Drug Revenue & Forecasts
        6.2.1 By Region - Global Prophylactic HIV Drug Revenue, 2017-2022
        6.2.2 By Region - Global Prophylactic HIV Drug Revenue, 2023-2028
        6.2.3 By Region - Global Prophylactic HIV Drug Revenue Market Share, 2017-2028
    6.3 By Region - Global Prophylactic HIV Drug Sales & Forecasts
        6.3.1 By Region - Global Prophylactic HIV Drug Sales, 2017-2022
        6.3.2 By Region - Global Prophylactic HIV Drug Sales, 2023-2028
        6.3.3 By Region - Global Prophylactic HIV Drug Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Prophylactic HIV Drug Revenue, 2017-2028
        6.4.2 By Country - North America Prophylactic HIV Drug Sales, 2017-2028
        6.4.3 US Prophylactic HIV Drug Market Size, 2017-2028
        6.4.4 Canada Prophylactic HIV Drug Market Size, 2017-2028
        6.4.5 Mexico Prophylactic HIV Drug Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Prophylactic HIV Drug Revenue, 2017-2028
        6.5.2 By Country - Europe Prophylactic HIV Drug Sales, 2017-2028
        6.5.3 Germany Prophylactic HIV Drug Market Size, 2017-2028
        6.5.4 France Prophylactic HIV Drug Market Size, 2017-2028
        6.5.5 U.K. Prophylactic HIV Drug Market Size, 2017-2028
        6.5.6 Italy Prophylactic HIV Drug Market Size, 2017-2028
        6.5.7 Russia Prophylactic HIV Drug Market Size, 2017-2028
        6.5.8 Nordic Countries Prophylactic HIV Drug Market Size, 2017-2028
        6.5.9 Benelux Prophylactic HIV Drug Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Prophylactic HIV Drug Revenue, 2017-2028
        6.6.2 By Region - Asia Prophylactic HIV Drug Sales, 2017-2028
        6.6.3 China Prophylactic HIV Drug Market Size, 2017-2028
        6.6.4 Japan Prophylactic HIV Drug Market Size, 2017-2028
        6.6.5 South Korea Prophylactic HIV Drug Market Size, 2017-2028
        6.6.6 Southeast Asia Prophylactic HIV Drug Market Size, 2017-2028
        6.6.7 India Prophylactic HIV Drug Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Prophylactic HIV Drug Revenue, 2017-2028
        6.7.2 By Country - South America Prophylactic HIV Drug Sales, 2017-2028
        6.7.3 Brazil Prophylactic HIV Drug Market Size, 2017-2028
        6.7.4 Argentina Prophylactic HIV Drug Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Prophylactic HIV Drug Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Prophylactic HIV Drug Sales, 2017-2028
        6.8.3 Turkey Prophylactic HIV Drug Market Size, 2017-2028
        6.8.4 Israel Prophylactic HIV Drug Market Size, 2017-2028
        6.8.5 Saudi Arabia Prophylactic HIV Drug Market Size, 2017-2028
        6.8.6 UAE Prophylactic HIV Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Gilead Sciences
        7.1.1 Gilead Sciences Corporate Summary
        7.1.2 Gilead Sciences Business Overview
        7.1.3 Gilead Sciences Prophylactic HIV Drug Major Product Offerings
        7.1.4 Gilead Sciences Prophylactic HIV Drug Sales and Revenue in Global (2017-2022)
        7.1.5 Gilead Sciences Key News
    7.2 Merck
        7.2.1 Merck Corporate Summary
        7.2.2 Merck Business Overview
        7.2.3 Merck Prophylactic HIV Drug Major Product Offerings
        7.2.4 Merck Prophylactic HIV Drug Sales and Revenue in Global (2017-2022)
        7.2.5 Merck Key News
    7.3 Mylan
        7.3.1 Mylan Corporate Summary
        7.3.2 Mylan Business Overview
        7.3.3 Mylan Prophylactic HIV Drug Major Product Offerings
        7.3.4 Mylan Prophylactic HIV Drug Sales and Revenue in Global (2017-2022)
        7.3.5 Mylan Key News
    7.4 Cipla
        7.4.1 Cipla Corporate Summary
        7.4.2 Cipla Business Overview
        7.4.3 Cipla Prophylactic HIV Drug Major Product Offerings
        7.4.4 Cipla Prophylactic HIV Drug Sales and Revenue in Global (2017-2022)
        7.4.5 Cipla Key News
    7.5 Bristol-Myers Squibb
        7.5.1 Bristol-Myers Squibb Corporate Summary
        7.5.2 Bristol-Myers Squibb Business Overview
        7.5.3 Bristol-Myers Squibb Prophylactic HIV Drug Major Product Offerings
        7.5.4 Bristol-Myers Squibb Prophylactic HIV Drug Sales and Revenue in Global (2017-2022)
        7.5.5 Bristol-Myers Squibb Key News
    7.6 Roche
        7.6.1 Roche Corporate Summary
        7.6.2 Roche Business Overview
        7.6.3 Roche Prophylactic HIV Drug Major Product Offerings
        7.6.4 Roche Prophylactic HIV Drug Sales and Revenue in Global (2017-2022)
        7.6.5 Roche Key News
8 Global Prophylactic HIV Drug Production Capacity, Analysis
    8.1 Global Prophylactic HIV Drug Production Capacity, 2017-2028
    8.2 Prophylactic HIV Drug Production Capacity of Key Manufacturers in Global Market
    8.3 Global Prophylactic HIV Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Prophylactic HIV Drug Supply Chain Analysis
    10.1 Prophylactic HIV Drug Industry Value Chain
    10.2 Prophylactic HIV Drug Upstream Market
    10.3 Prophylactic HIV Drug Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Prophylactic HIV Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

List of Tables
    Table 1. Key Players of Prophylactic HIV Drug in Global Market
    Table 2. Top Prophylactic HIV Drug Players in Global Market, Ranking by Revenue (2021)
    Table 3. Global Prophylactic HIV Drug Revenue by Companies, (US$, Mn), 2017-2022
    Table 4. Global Prophylactic HIV Drug Revenue Share by Companies, 2017-2022
    Table 5. Global Prophylactic HIV Drug Sales by Companies, (K Units), 2017-2022
    Table 6. Global Prophylactic HIV Drug Sales Share by Companies, 2017-2022
    Table 7. Key Manufacturers Prophylactic HIV Drug Price (2017-2022) & (USD/Unit)
    Table 8. Global Manufacturers Prophylactic HIV Drug Product Type
    Table 9. List of Global Tier 1 Prophylactic HIV Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Prophylactic HIV Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Prophylactic HIV Drug Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Global Prophylactic HIV Drug Revenue (US$, Mn), 2017-2022
    Table 13. By Type - Global Prophylactic HIV Drug Revenue (US$, Mn), 2023-2028
    Table 14. By Type - Global Prophylactic HIV Drug Sales (K Units), 2017-2022
    Table 15. By Type - Global Prophylactic HIV Drug Sales (K Units), 2023-2028
    Table 16. By Application – Global Prophylactic HIV Drug Revenue, (US$, Mn), 2021 & 2028
    Table 17. By Application - Global Prophylactic HIV Drug Revenue (US$, Mn), 2017-2022
    Table 18. By Application - Global Prophylactic HIV Drug Revenue (US$, Mn), 2023-2028
    Table 19. By Application - Global Prophylactic HIV Drug Sales (K Units), 2017-2022
    Table 20. By Application - Global Prophylactic HIV Drug Sales (K Units), 2023-2028
    Table 21. By Region – Global Prophylactic HIV Drug Revenue, (US$, Mn), 2021 VS 2028
    Table 22. By Region - Global Prophylactic HIV Drug Revenue (US$, Mn), 2017-2022
    Table 23. By Region - Global Prophylactic HIV Drug Revenue (US$, Mn), 2023-2028
    Table 24. By Region - Global Prophylactic HIV Drug Sales (K Units), 2017-2022
    Table 25. By Region - Global Prophylactic HIV Drug Sales (K Units), 2023-2028
    Table 26. By Country - North America Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - North America Prophylactic HIV Drug Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - North America Prophylactic HIV Drug Sales, (K Units), 2017-2022
    Table 29. By Country - North America Prophylactic HIV Drug Sales, (K Units), 2023-2028
    Table 30. By Country - Europe Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2022
    Table 31. By Country - Europe Prophylactic HIV Drug Revenue, (US$, Mn), 2023-2028
    Table 32. By Country - Europe Prophylactic HIV Drug Sales, (K Units), 2017-2022
    Table 33. By Country - Europe Prophylactic HIV Drug Sales, (K Units), 2023-2028
    Table 34. By Region - Asia Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2022
    Table 35. By Region - Asia Prophylactic HIV Drug Revenue, (US$, Mn), 2023-2028
    Table 36. By Region - Asia Prophylactic HIV Drug Sales, (K Units), 2017-2022
    Table 37. By Region - Asia Prophylactic HIV Drug Sales, (K Units), 2023-2028
    Table 38. By Country - South America Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2022
    Table 39. By Country - South America Prophylactic HIV Drug Revenue, (US$, Mn), 2023-2028
    Table 40. By Country - South America Prophylactic HIV Drug Sales, (K Units), 2017-2022
    Table 41. By Country - South America Prophylactic HIV Drug Sales, (K Units), 2023-2028
    Table 42. By Country - Middle East & Africa Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2022
    Table 43. By Country - Middle East & Africa Prophylactic HIV Drug Revenue, (US$, Mn), 2023-2028
    Table 44. By Country - Middle East & Africa Prophylactic HIV Drug Sales, (K Units), 2017-2022
    Table 45. By Country - Middle East & Africa Prophylactic HIV Drug Sales, (K Units), 2023-2028
    Table 46. Gilead Sciences Corporate Summary
    Table 47. Gilead Sciences Prophylactic HIV Drug Product Offerings
    Table 48. Gilead Sciences Prophylactic HIV Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 49. Merck Corporate Summary
    Table 50. Merck Prophylactic HIV Drug Product Offerings
    Table 51. Merck Prophylactic HIV Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 52. Mylan Corporate Summary
    Table 53. Mylan Prophylactic HIV Drug Product Offerings
    Table 54. Mylan Prophylactic HIV Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 55. Cipla Corporate Summary
    Table 56. Cipla Prophylactic HIV Drug Product Offerings
    Table 57. Cipla Prophylactic HIV Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 58. Bristol-Myers Squibb Corporate Summary
    Table 59. Bristol-Myers Squibb Prophylactic HIV Drug Product Offerings
    Table 60. Bristol-Myers Squibb Prophylactic HIV Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 61. Roche Corporate Summary
    Table 62. Roche Prophylactic HIV Drug Product Offerings
    Table 63. Roche Prophylactic HIV Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 64. Prophylactic HIV Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
    Table 65. Global Prophylactic HIV Drug Capacity Market Share of Key Manufacturers, 2020-2022
    Table 66. Global Prophylactic HIV Drug Production by Region, 2017-2022 (K Units)
    Table 67. Global Prophylactic HIV Drug Production by Region, 2023-2028 (K Units)
    Table 68. Prophylactic HIV Drug Market Opportunities & Trends in Global Market
    Table 69. Prophylactic HIV Drug Market Drivers in Global Market
    Table 70. Prophylactic HIV Drug Market Restraints in Global Market
    Table 71. Prophylactic HIV Drug Raw Materials
    Table 72. Prophylactic HIV Drug Raw Materials Suppliers in Global Market
    Table 73. Typical Prophylactic HIV Drug Downstream
    Table 74. Prophylactic HIV Drug Downstream Clients in Global Market
    Table 75. Prophylactic HIV Drug Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Prophylactic HIV Drug Segment by Type
    Figure 2. Prophylactic HIV Drug Segment by Application
    Figure 3. Global Prophylactic HIV Drug Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Prophylactic HIV Drug Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Prophylactic HIV Drug Revenue, 2017-2028 (US$, Mn)
    Figure 7. Prophylactic HIV Drug Sales in Global Market: 2017-2028 (K Units)
    Figure 8. The Top 3 and 5 Players Market Share by Prophylactic HIV Drug Revenue in 2021
    Figure 9. By Type - Global Prophylactic HIV Drug Sales Market Share, 2017-2028
    Figure 10. By Type - Global Prophylactic HIV Drug Revenue Market Share, 2017-2028
    Figure 11. By Type - Global Prophylactic HIV Drug Price (USD/Unit), 2017-2028
    Figure 12. By Application - Global Prophylactic HIV Drug Sales Market Share, 2017-2028
    Figure 13. By Application - Global Prophylactic HIV Drug Revenue Market Share, 2017-2028
    Figure 14. By Application - Global Prophylactic HIV Drug Price (USD/Unit), 2017-2028
    Figure 15. By Region - Global Prophylactic HIV Drug Sales Market Share, 2017-2028
    Figure 16. By Region - Global Prophylactic HIV Drug Revenue Market Share, 2017-2028
    Figure 17. By Country - North America Prophylactic HIV Drug Revenue Market Share, 2017-2028
    Figure 18. By Country - North America Prophylactic HIV Drug Sales Market Share, 2017-2028
    Figure 19. US Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
    Figure 20. Canada Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
    Figure 21. Mexico Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
    Figure 22. By Country - Europe Prophylactic HIV Drug Revenue Market Share, 2017-2028
    Figure 23. By Country - Europe Prophylactic HIV Drug Sales Market Share, 2017-2028
    Figure 24. Germany Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
    Figure 25. France Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
    Figure 26. U.K. Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
    Figure 27. Italy Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
    Figure 28. Russia Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
    Figure 29. Nordic Countries Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
    Figure 30. Benelux Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
    Figure 31. By Region - Asia Prophylactic HIV Drug Revenue Market Share, 2017-2028
    Figure 32. By Region - Asia Prophylactic HIV Drug Sales Market Share, 2017-2028
    Figure 33. China Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
    Figure 34. Japan Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
    Figure 35. South Korea Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
    Figure 36. Southeast Asia Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
    Figure 37. India Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
    Figure 38. By Country - South America Prophylactic HIV Drug Revenue Market Share, 2017-2028
    Figure 39. By Country - South America Prophylactic HIV Drug Sales Market Share, 2017-2028
    Figure 40. Brazil Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
    Figure 41. Argentina Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
    Figure 42. By Country - Middle East & Africa Prophylactic HIV Drug Revenue Market Share, 2017-2028
    Figure 43. By Country - Middle East & Africa Prophylactic HIV Drug Sales Market Share, 2017-2028
    Figure 44. Turkey Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
    Figure 45. Israel Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
    Figure 46. Saudi Arabia Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
    Figure 47. UAE Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
    Figure 48. Global Prophylactic HIV Drug Production Capacity (K Units), 2017-2028
    Figure 49. The Percentage of Production Prophylactic HIV Drug by Region, 2021 VS 2028
    Figure 50. Prophylactic HIV Drug Industry Value Chain
    Figure 51. Marketing Channels
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
77
Frequently Asked Questions
Prophylactic HIV Drug Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prophylactic HIV Drug Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prophylactic HIV Drug Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Cetanol Market

Cetanol is considered as a long chain compound falls under the category of organic  ... Read More

Tallow Amine Market

Tallow amines represents the wide range of non-ionic surfactants derived from animal fats i.e. ta ... Read More

Fixing Agent Market

A fixing agent is one of the important element in dyeing and printing industry, whi ... Read More